| Application no. and date | 01931458.2 (espacenet) (Federated) (European Patent Register), 20010510 | | Patent/reg. no. and date | DK/EP 1282438, 20050803 | | Publication date | 20030212 | | Priority no. and date | DK 200000778, 20000510, DK 200000771, 20000510, US 206194 P, 20000522, US 206212 P, 20000522, DK 200000871, 20000606, US 212857 P, 20000620 | | EP pub. no. and date |
EP 1282438 20030212 | | Effective date | | | Applicant/owner | Novo Nordisk Health Care AG, Andreasstrasse 15
8050 Zürich, CH | | Applicant ref. no. | 6193.205-DK | | Inventor | PETERSEN, Lars, Christian, Havevej 4, 2970 Hørsholm, DK,
ROJKJAER, Rasmus, Folkevej 30A, 2820 Gentofte, DK,
HEDNER, Ulla, Caritasgatan 19
S-216 18 Malmo, SE | | Representative | Novo Nordisk
Corporate Patents, Novo Allé, 2880 Bagsværd, DK | | Opponent | | | IPC Class | A61K 38/36 (2006.01) , A61P 7/04 (2006.01) | | Title | Farmaceutisk sammensætning omfattende en faktor VIIa og en faktor XIII | | Int. application no. | DK2001000322 | | Int. publication no. | WO2001085198 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
